The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Renal Replacement and End Stage Renal Disease Therapy Market Research Report 2025

Global Renal Replacement and End Stage Renal Disease Therapy Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1683464

No of Pages : 88

Synopsis
Renal replacement therapy (RRT) is therapy that replaces the normal blood-filtering function of the kidneys. It is used when the kidneys are not working well, which is called kidney failure and includes acute kidney injury and chronic kidney disease. Renal replacement therapy includes dialysis (hemodialysis or peritoneal dialysis), hemofiltration, and hemodiafiltration, which are various ways of filtration of blood with or without machines. Renal replacement therapy also includes kidney transplantation, which is the ultimate form of replacement in that the old kidney is replaced by a donor kidney.

The global Renal Replacement and End Stage Renal Disease Therapy market was valued at US$ 99080 million in 2023 and is anticipated to reach US$ 135550 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.

The Renal Replacement and End-Stage Renal Disease (ESRD) Therapy market is primarily driven by the increasing prevalence of chronic kidney diseases and the growing demand for effective treatment options. Renal replacement therapies, including hemodialysis, peritoneal dialysis, and kidney transplantation, play a vital role in managing ESRD, a condition characterized by kidney function decline to a point where life-sustaining treatment is necessary. The rising global burden of ESRD and the need for improved patient outcomes contribute to market growth as healthcare systems seek advanced therapies that offer enhanced dialysis efficiency, patient comfort, and reduced treatment-related complications. Moreover, technological advancements in dialysis equipment, access to kidney transplants, and remote patient monitoring align with improved therapeutic options, fostering market adoption. However, the market also faces challenges, including the high cost of dialysis procedures, limited availability of organ donors, and concerns related to infection risk in immunocompromised patients. Additionally, addressing regulatory compliance, patient education, and disparities in access to care can pose obstacles for healthcare providers and manufacturers. To succeed, stakeholders must focus on innovation in therapy delivery, affordability, and addressing the challenges to provide patients with comprehensive renal replacement options that enhance their quality of life and contribute to better management of ESRD.

This report aims to provide a comprehensive presentation of the global market for Renal Replacement and End Stage Renal Disease Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Renal Replacement and End Stage Renal Disease Therapy.

Report Scope

The Renal Replacement and End Stage Renal Disease Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Renal Replacement and End Stage Renal Disease Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Renal Replacement and End Stage Renal Disease Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

Fresenius

DaVita

Baxter

US rental care

B.Braun

Diaverum

Nipro

Asahi Kasei

Nikkiso

Toray

WEGO

JMS

Medtronic

SWS Hemodialysis Care

Segment by Type

Devices

Consumables

Services

Segment by Application

Hospital

Dialysis Center

Other

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Renal Replacement and End Stage Renal Disease Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Renal Replacement and End Stage Renal Disease Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Devices

1.2.3 Consumables

1.2.4 Services

1.3 Market by Application

1.3.1 Global Renal Replacement and End Stage Renal Disease Therapy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Dialysis Center

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Renal Replacement and End Stage Renal Disease Therapy Market Perspective (2019-2030)

2.2 Renal Replacement and End Stage Renal Disease Therapy Growth Trends by Region

2.2.1 Global Renal Replacement and End Stage Renal Disease Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Renal Replacement and End Stage Renal Disease Therapy Historic Market Size by Region (2019-2024)

2.2.3 Renal Replacement and End Stage Renal Disease Therapy Forecasted Market Size by Region (2025-2030)

2.3 Renal Replacement and End Stage Renal Disease Therapy Market Dynamics

2.3.1 Renal Replacement and End Stage Renal Disease Therapy Industry Trends

2.3.2 Renal Replacement and End Stage Renal Disease Therapy Market Drivers

2.3.3 Renal Replacement and End Stage Renal Disease Therapy Market Challenges

2.3.4 Renal Replacement and End Stage Renal Disease Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Renal Replacement and End Stage Renal Disease Therapy Players by Revenue

3.1.1 Global Top Renal Replacement and End Stage Renal Disease Therapy Players by Revenue (2019-2024)

3.1.2 Global Renal Replacement and End Stage Renal Disease Therapy Revenue Market Share by Players (2019-2024)

3.2 Global Renal Replacement and End Stage Renal Disease Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Renal Replacement and End Stage Renal Disease Therapy Revenue

3.4 Global Renal Replacement and End Stage Renal Disease Therapy Market Concentration Ratio

3.4.1 Global Renal Replacement and End Stage Renal Disease Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Renal Replacement and End Stage Renal Disease Therapy Revenue in 2023

3.5 Renal Replacement and End Stage Renal Disease Therapy Key Players Head office and Area Served

3.6 Key Players Renal Replacement and End Stage Renal Disease Therapy Product Solution and Service

3.7 Date of Enter into Renal Replacement and End Stage Renal Disease Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Renal Replacement and End Stage Renal Disease Therapy Breakdown Data by Type

4.1 Global Renal Replacement and End Stage Renal Disease Therapy Historic Market Size by Type (2019-2024)

4.2 Global Renal Replacement and End Stage Renal Disease Therapy Forecasted Market Size by Type (2025-2030)

5 Renal Replacement and End Stage Renal Disease Therapy Breakdown Data by Application

5.1 Global Renal Replacement and End Stage Renal Disease Therapy Historic Market Size by Application (2019-2024)

5.2 Global Renal Replacement and End Stage Renal Disease Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Renal Replacement and End Stage Renal Disease Therapy Market Size (2019-2030)

6.2 North America Renal Replacement and End Stage Renal Disease Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Renal Replacement and End Stage Renal Disease Therapy Market Size by Country (2019-2024)

6.4 North America Renal Replacement and End Stage Renal Disease Therapy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Renal Replacement and End Stage Renal Disease Therapy Market Size (2019-2030)

7.2 Europe Renal Replacement and End Stage Renal Disease Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Renal Replacement and End Stage Renal Disease Therapy Market Size by Country (2019-2024)

7.4 Europe Renal Replacement and End Stage Renal Disease Therapy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Renal Replacement and End Stage Renal Disease Therapy Market Size (2019-2030)

8.2 Asia-Pacific Renal Replacement and End Stage Renal Disease Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Renal Replacement and End Stage Renal Disease Therapy Market Size by Region (2019-2024)

8.4 Asia-Pacific Renal Replacement and End Stage Renal Disease Therapy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Renal Replacement and End Stage Renal Disease Therapy Market Size (2019-2030)

9.2 Latin America Renal Replacement and End Stage Renal Disease Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Renal Replacement and End Stage Renal Disease Therapy Market Size by Country (2019-2024)

9.4 Latin America Renal Replacement and End Stage Renal Disease Therapy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Renal Replacement and End Stage Renal Disease Therapy Market Size (2019-2030)

10.2 Middle East & Africa Renal Replacement and End Stage Renal Disease Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Renal Replacement and End Stage Renal Disease Therapy Market Size by Country (2019-2024)

10.4 Middle East & Africa Renal Replacement and End Stage Renal Disease Therapy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Fresenius

11.1.1 Fresenius Company Detail

11.1.2 Fresenius Business Overview

11.1.3 Fresenius Renal Replacement and End Stage Renal Disease Therapy Introduction

11.1.4 Fresenius Revenue in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024)

11.1.5 Fresenius Recent Development

11.2 DaVita

11.2.1 DaVita Company Detail

11.2.2 DaVita Business Overview

11.2.3 DaVita Renal Replacement and End Stage Renal Disease Therapy Introduction

11.2.4 DaVita Revenue in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024)

11.2.5 DaVita Recent Development

11.3 Baxter

11.3.1 Baxter Company Detail

11.3.2 Baxter Business Overview

11.3.3 Baxter Renal Replacement and End Stage Renal Disease Therapy Introduction

11.3.4 Baxter Revenue in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024)

11.3.5 Baxter Recent Development

11.4 US rental care

11.4.1 US rental care Company Detail

11.4.2 US rental care Business Overview

11.4.3 US rental care Renal Replacement and End Stage Renal Disease Therapy Introduction

11.4.4 US rental care Revenue in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024)

11.4.5 US rental care Recent Development

11.5 B.Braun

11.5.1 B.Braun Company Detail

11.5.2 B.Braun Business Overview

11.5.3 B.Braun Renal Replacement and End Stage Renal Disease Therapy Introduction

11.5.4 B.Braun Revenue in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024)

11.5.5 B.Braun Recent Development

11.6 Diaverum

11.6.1 Diaverum Company Detail

11.6.2 Diaverum Business Overview

11.6.3 Diaverum Renal Replacement and End Stage Renal Disease Therapy Introduction

11.6.4 Diaverum Revenue in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024)

11.6.5 Diaverum Recent Development

11.7 Nipro

11.7.1 Nipro Company Detail

11.7.2 Nipro Business Overview

11.7.3 Nipro Renal Replacement and End Stage Renal Disease Therapy Introduction

11.7.4 Nipro Revenue in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024)

11.7.5 Nipro Recent Development

11.8 Asahi Kasei

11.8.1 Asahi Kasei Company Detail

11.8.2 Asahi Kasei Business Overview

11.8.3 Asahi Kasei Renal Replacement and End Stage Renal Disease Therapy Introduction

11.8.4 Asahi Kasei Revenue in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024)

11.8.5 Asahi Kasei Recent Development

11.9 Nikkiso

11.9.1 Nikkiso Company Detail

11.9.2 Nikkiso Business Overview

11.9.3 Nikkiso Renal Replacement and End Stage Renal Disease Therapy Introduction

11.9.4 Nikkiso Revenue in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024)

11.9.5 Nikkiso Recent Development

11.10 Toray

11.10.1 Toray Company Detail

11.10.2 Toray Business Overview

11.10.3 Toray Renal Replacement and End Stage Renal Disease Therapy Introduction

11.10.4 Toray Revenue in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024)

11.10.5 Toray Recent Development

11.11 WEGO

11.11.1 WEGO Company Detail

11.11.2 WEGO Business Overview

11.11.3 WEGO Renal Replacement and End Stage Renal Disease Therapy Introduction

11.11.4 WEGO Revenue in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024)

11.11.5 WEGO Recent Development

11.12 JMS

11.12.1 JMS Company Detail

11.12.2 JMS Business Overview

11.12.3 JMS Renal Replacement and End Stage Renal Disease Therapy Introduction

11.12.4 JMS Revenue in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024)

11.12.5 JMS Recent Development

11.13 Medtronic

11.13.1 Medtronic Company Detail

11.13.2 Medtronic Business Overview

11.13.3 Medtronic Renal Replacement and End Stage Renal Disease Therapy Introduction

11.13.4 Medtronic Revenue in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024)

11.13.5 Medtronic Recent Development

11.14 SWS Hemodialysis Care

11.14.1 SWS Hemodialysis Care Company Detail

11.14.2 SWS Hemodialysis Care Business Overview

11.14.3 SWS Hemodialysis Care Renal Replacement and End Stage Renal Disease Therapy Introduction

11.14.4 SWS Hemodialysis Care Revenue in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024)

11.14.5 SWS Hemodialysis Care Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details
List of Tables
List of Tables

Table 1. Global Renal Replacement and End Stage Renal Disease Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Devices

Table 3. Key Players of Consumables

Table 4. Key Players of Services

Table 5. Global Renal Replacement and End Stage Renal Disease Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Renal Replacement and End Stage Renal Disease Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Renal Replacement and End Stage Renal Disease Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Renal Replacement and End Stage Renal Disease Therapy Market Share by Region (2019-2024)

Table 9. Global Renal Replacement and End Stage Renal Disease Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Renal Replacement and End Stage Renal Disease Therapy Market Share by Region (2025-2030)

Table 11. Renal Replacement and End Stage Renal Disease Therapy Market Trends

Table 12. Renal Replacement and End Stage Renal Disease Therapy Market Drivers

Table 13. Renal Replacement and End Stage Renal Disease Therapy Market Challenges

Table 14. Renal Replacement and End Stage Renal Disease Therapy Market Restraints

Table 15. Global Renal Replacement and End Stage Renal Disease Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Renal Replacement and End Stage Renal Disease Therapy Market Share by Players (2019-2024)

Table 17. Global Top Renal Replacement and End Stage Renal Disease Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Replacement and End Stage Renal Disease Therapy as of 2023)

Table 18. Ranking of Global Top Renal Replacement and End Stage Renal Disease Therapy Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Renal Replacement and End Stage Renal Disease Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Renal Replacement and End Stage Renal Disease Therapy Product Solution and Service

Table 22. Date of Enter into Renal Replacement and End Stage Renal Disease Therapy Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Renal Replacement and End Stage Renal Disease Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Renal Replacement and End Stage Renal Disease Therapy Revenue Market Share by Type (2019-2024)

Table 26. Global Renal Replacement and End Stage Renal Disease Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Renal Replacement and End Stage Renal Disease Therapy Revenue Market Share by Type (2025-2030)

Table 28. Global Renal Replacement and End Stage Renal Disease Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Renal Replacement and End Stage Renal Disease Therapy Revenue Market Share by Application (2019-2024)

Table 30. Global Renal Replacement and End Stage Renal Disease Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Renal Replacement and End Stage Renal Disease Therapy Revenue Market Share by Application (2025-2030)

Table 32. North America Renal Replacement and End Stage Renal Disease Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Renal Replacement and End Stage Renal Disease Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Renal Replacement and End Stage Renal Disease Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Renal Replacement and End Stage Renal Disease Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Renal Replacement and End Stage Renal Disease Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Renal Replacement and End Stage Renal Disease Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Renal Replacement and End Stage Renal Disease Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Renal Replacement and End Stage Renal Disease Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Renal Replacement and End Stage Renal Disease Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Renal Replacement and End Stage Renal Disease Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Renal Replacement and End Stage Renal Disease Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Renal Replacement and End Stage Renal Disease Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Renal Replacement and End Stage Renal Disease Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Renal Replacement and End Stage Renal Disease Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Renal Replacement and End Stage Renal Disease Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 47. Fresenius Company Detail

Table 48. Fresenius Business Overview

Table 49. Fresenius Renal Replacement and End Stage Renal Disease Therapy Product

Table 50. Fresenius Revenue in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024) & (US$ Million)

Table 51. Fresenius Recent Development

Table 52. DaVita Company Detail

Table 53. DaVita Business Overview

Table 54. DaVita Renal Replacement and End Stage Renal Disease Therapy Product

Table 55. DaVita Revenue in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024) & (US$ Million)

Table 56. DaVita Recent Development

Table 57. Baxter Company Detail

Table 58. Baxter Business Overview

Table 59. Baxter Renal Replacement and End Stage Renal Disease Therapy Product

Table 60. Baxter Revenue in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024) & (US$ Million)

Table 61. Baxter Recent Development

Table 62. US rental care Company Detail

Table 63. US rental care Business Overview

Table 64. US rental care Renal Replacement and End Stage Renal Disease Therapy Product

Table 65. US rental care Revenue in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024) & (US$ Million)

Table 66. US rental care Recent Development

Table 67. B.Braun Company Detail

Table 68. B.Braun Business Overview

Table 69. B.Braun Renal Replacement and End Stage Renal Disease Therapy Product

Table 70. B.Braun Revenue in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024) & (US$ Million)

Table 71. B.Braun Recent Development

Table 72. Diaverum Company Detail

Table 73. Diaverum Business Overview

Table 74. Diaverum Renal Replacement and End Stage Renal Disease Therapy Product

Table 75. Diaverum Revenue in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024) & (US$ Million)

Table 76. Diaverum Recent Development

Table 77. Nipro Company Detail

Table 78. Nipro Business Overview

Table 79. Nipro Renal Replacement and End Stage Renal Disease Therapy Product

Table 80. Nipro Revenue in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024) & (US$ Million)

Table 81. Nipro Recent Development

Table 82. Asahi Kasei Company Detail

Table 83. Asahi Kasei Business Overview

Table 84. Asahi Kasei Renal Replacement and End Stage Renal Disease Therapy Product

Table 85. Asahi Kasei Revenue in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024) & (US$ Million)

Table 86. Asahi Kasei Recent Development

Table 87. Nikkiso Company Detail

Table 88. Nikkiso Business Overview

Table 89. Nikkiso Renal Replacement and End Stage Renal Disease Therapy Product

Table 90. Nikkiso Revenue in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024) & (US$ Million)

Table 91. Nikkiso Recent Development

Table 92. Toray Company Detail

Table 93. Toray Business Overview

Table 94. Toray Renal Replacement and End Stage Renal Disease Therapy Product

Table 95. Toray Revenue in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024) & (US$ Million)

Table 96. Toray Recent Development

Table 97. WEGO Company Detail

Table 98. WEGO Business Overview

Table 99. WEGO Renal Replacement and End Stage Renal Disease Therapy Product

Table 100. WEGO Revenue in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024) & (US$ Million)

Table 101. WEGO Recent Development

Table 102. JMS Company Detail

Table 103. JMS Business Overview

Table 104. JMS Renal Replacement and End Stage Renal Disease Therapy Product

Table 105. JMS Revenue in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024) & (US$ Million)

Table 106. JMS Recent Development

Table 107. Medtronic Company Detail

Table 108. Medtronic Business Overview

Table 109. Medtronic Renal Replacement and End Stage Renal Disease Therapy Product

Table 110. Medtronic Revenue in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024) & (US$ Million)

Table 111. Medtronic Recent Development

Table 112. SWS Hemodialysis Care Company Detail

Table 113. SWS Hemodialysis Care Business Overview

Table 114. SWS Hemodialysis Care Renal Replacement and End Stage Renal Disease Therapy Product

Table 115. SWS Hemodialysis Care Revenue in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024) & (US$ Million)

Table 116. SWS Hemodialysis Care Recent Development

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Renal Replacement and End Stage Renal Disease Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Renal Replacement and End Stage Renal Disease Therapy Market Share by Type: 2023 VS 2030

Figure 3. Devices Features

Figure 4. Consumables Features

Figure 5. Services Features

Figure 6. Global Renal Replacement and End Stage Renal Disease Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Renal Replacement and End Stage Renal Disease Therapy Market Share by Application: 2023 VS 2030

Figure 8. Hospital Case Studies

Figure 9. Dialysis Center Case Studies

Figure 10. Other Case Studies

Figure 11. Renal Replacement and End Stage Renal Disease Therapy Report Years Considered

Figure 12. Global Renal Replacement and End Stage Renal Disease Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Renal Replacement and End Stage Renal Disease Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Renal Replacement and End Stage Renal Disease Therapy Market Share by Region: 2023 VS 2030

Figure 15. Global Renal Replacement and End Stage Renal Disease Therapy Market Share by Players in 2023

Figure 16. Global Top Renal Replacement and End Stage Renal Disease Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Replacement and End Stage Renal Disease Therapy as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Renal Replacement and End Stage Renal Disease Therapy Revenue in 2023

Figure 18. North America Renal Replacement and End Stage Renal Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Renal Replacement and End Stage Renal Disease Therapy Market Share by Country (2019-2030)

Figure 20. United States Renal Replacement and End Stage Renal Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Renal Replacement and End Stage Renal Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Renal Replacement and End Stage Renal Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Renal Replacement and End Stage Renal Disease Therapy Market Share by Country (2019-2030)

Figure 24. Germany Renal Replacement and End Stage Renal Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Renal Replacement and End Stage Renal Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Renal Replacement and End Stage Renal Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Renal Replacement and End Stage Renal Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Renal Replacement and End Stage Renal Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Renal Replacement and End Stage Renal Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Renal Replacement and End Stage Renal Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Renal Replacement and End Stage Renal Disease Therapy Market Share by Region (2019-2030)

Figure 32. China Renal Replacement and End Stage Renal Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Renal Replacement and End Stage Renal Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Renal Replacement and End Stage Renal Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Renal Replacement and End Stage Renal Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Renal Replacement and End Stage Renal Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Renal Replacement and End Stage Renal Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Renal Replacement and End Stage Renal Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Renal Replacement and End Stage Renal Disease Therapy Market Share by Country (2019-2030)

Figure 40. Mexico Renal Replacement and End Stage Renal Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Renal Replacement and End Stage Renal Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Renal Replacement and End Stage Renal Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Renal Replacement and End Stage Renal Disease Therapy Market Share by Country (2019-2030)

Figure 44. Turkey Renal Replacement and End Stage Renal Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Renal Replacement and End Stage Renal Disease Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Fresenius Revenue Growth Rate in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024)

Figure 47. DaVita Revenue Growth Rate in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024)

Figure 48. Baxter Revenue Growth Rate in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024)

Figure 49. US rental care Revenue Growth Rate in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024)

Figure 50. B.Braun Revenue Growth Rate in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024)

Figure 51. Diaverum Revenue Growth Rate in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024)

Figure 52. Nipro Revenue Growth Rate in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024)

Figure 53. Asahi Kasei Revenue Growth Rate in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024)

Figure 54. Nikkiso Revenue Growth Rate in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024)

Figure 55. Toray Revenue Growth Rate in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024)

Figure 56. WEGO Revenue Growth Rate in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024)

Figure 57. JMS Revenue Growth Rate in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024)

Figure 58. Medtronic Revenue Growth Rate in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024)

Figure 59. SWS Hemodialysis Care Revenue Growth Rate in Renal Replacement and End Stage Renal Disease Therapy Business (2019-2024)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’